Open AccessDynamics of circulating microparticles in chronic kidney disease and transplantation: Is it really reliable marker?
Author(s) -
İsmail Dursun,
Sibel Yel,
Emel Kabakoğlu Ünsür
Publication year - 2015
Publication title -
world journal of transplantation
Language(s) - English
Resource type - Journals
ISSN - 2220-3230
DOI - 10.5500/wjt.v5.i4.267
Subject(s) - endothelial dysfunction , kidney disease , cd31 , medicine , asymptomatic , vascular disease , endothelium , endothelial stem cell , disease , transplantation , risk factor , kidney , pathology , immunology , angiogenesis , biology , biochemistry , in vitro
The deterioration of endothelial structure plays a very important role in the development of vascular diseases. It is believed that endothelial dysfunction starts in the early stage of kidney disease and is a risk factor of an unfavorable cardiovascular prognosis. Because a direct assessment of biological states in endothelial cells is not applicable, the measurement of endothelial microparticles (EMPs) detached from endothelium during activation or apoptosis is thought to be a marker of early vascular disease and endothelial dysfunction in children with chronic kidney disease (CKD). Few studies have shown increased circulating EMPs and its relationship with cardiovascular risk factors in patients with CKD. MPs contain membrane proteins and cytosolic material derived from the cell from which they originate. EMPs having CD144, CD 146, CD31(+)/CD41(-), CD51 and CD105 may be used to evaluate the vascular endothelial cell damage and determine asymptomatic patients who might be at higher risk of developing cardiovascular disease in CKD and renal transplant.